HR Execs on the Move

Diamond Recovery Centers

www.diamondrecoverycenter.com

 
Diamond Recovery Centers is run by members in recovery, industry-leading professionals, and world-class clinicians. Our mission statement is ” If we put the clients and their needs first, everything else will fall in place”. Our only goal is to help those struggling with Mental Health and Substance Abuse one client at a time.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Consultant People

Consultant People, LP is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Marathon Kids

Marathon Kids is a nonprofit organization, headquartered in Austin, TX, that is dedicated to improving the health of children by providing them with the motivation, tools and support to live happier, healthier lifestyles. Marathon Kids started out with the simple mission to introduce children to the joy of running, but it has evolved into the only evidence-based running/walking program for elementary-school kids in the United States. We`ve stood up to rigorous tests to prove that our program mitigates the negative health effects of a sedentary lifestyle and ardently pushes for access around the country. The vast majority of kids don`t get the 60 minutes of physical activity they need each day. Marathon Kids running clubs are proven effective—even transformational—for millions of kids, families, organizations and schools.

Community Hospital Corporation

Community Hospital Corporation owns, manages and consults with hospitals through three distinct organizations — CHC Hospitals, CHC Consulting and CHC ContinueCARE, which share a common purpose to guide, support and enhance the mission of community hospitals and healthcare providers.

Interlace Medical

Interlace Medical, Inc. is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.